Detection and quantification of HIV-1 specific CD4 helper and CD8 cytotoxic cells: Their role in HIV-1-infected individuals and vaccine recipients

HIV Medicine

Volumn 2, Issue 3, 2001, Pages 146-153

  Imami, N ^a   Hardy, G ^a   Pires, A ^a   Burton, C ^a   Sullivan, A ^a   Gotch, F ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

CD4; CD8; Detection; HIV 1 specific; Quantification

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; METHODOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; REGULATORY MECHANISM; REVIEW; SEROLOGY; VIREMIA;

AIDS VACCINES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; HIV INFECTIONS; HIV-1; HUMANS;

EID: 0035202849     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1293.2001.00068.x     Document Type: Review

References (69)

1. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Differential CTL responses to HIV-1 and Epstein-Barr virus in late disease
2. Cytotoxic T-cell immunity to influenza
3. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection
4. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice
5. Viral immune evasion due to persistence of activated T cells without effector function
6. Anti-HIV cellular immunity: Recent advances towards vaccine design
7. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
8. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
9. Differences in antigen presentation to MHC class I- and class II-restricted influenza virus-specific cytolytic T lymphocyte clones
10. Sequence analysis of peptides bound to MHC class II molecules
11. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad
12. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1
13. T cell activation and the cytoskeleton
14. Transcription factors of the NFAT family: Regulation and function
15. Lymphocyte specificity to protein antigens. I. Characterization of the antigen-induced in vitro T cell-dependent proliferative response with lymph node cells from primed mice
16. Enumeration of IL 2-secreting helper T cells by limiting dilution analysis, and demonstration of unexpectedly high levels of IL 2 production per responding cell
17. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals
18. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging
19. T1→T2 switch is a critical step in the etiology of HIV infection
20. The Th1-Th2 hypothesis of HIV infection: New insights
21. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells
22. Effect of HIV infection on the frequency of cytokine-secreting cells in human peripheral blood
23. Enzymatic amplification staining for flow cytometric analysis of cell surface molecules
24. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency
25. Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis
26. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1
27. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
28. HLA DR-1 tetramers delineate HIV-1-specific CD3+ CD4+ cells
29. Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy
30. Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: Impact of highly active antiretroviral therapy
31. Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease
32. Decreased accessory cell function of macrophages after infection with human immunodeficiency virus type 1 in vitro
33. The moving target: Mechanisms of HIV persistence during primary infection
34. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition
35. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection
36. Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans
37. The Th1/Th2 paradigm
38. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures
39. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
40. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides
41. Limiting dilution assays. Experimental design and statistical analysis
42. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons
43. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: In vitro quantitation of effector cell populations with p17 and p24 specificities
44. Rapid effector function in CD8+ memory T cells
45. Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis
46. A sensitive ELISPOT assay to detect low-frequency human T lymphocytes
47. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals
48. An algorithm for evaluating human cytotoxic T lymphocyte responses to candidate AIDS vaccines
49. HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function
50. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
51. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo
52. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex
53. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication
54. Controlling HIV pathogenesis: The role of the noncytotoxic anti-HIV response of CD8+ T cells
55. CD8+ anti-human immunodeficiency virus suppressor activity (CASA) in response to antiretroviral therapy: Loss of CASA is associated with loss of viremia
56. Assessment of β chemokines and IL-16 in HIV-1 infected individuals: Impact of highly active antiretroviral therapy
57. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors
58. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
59. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics
60. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells
61. Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term non-progressors
62. Cytotoxic T cells recognize fragments of the influenza nucleoprotein
63. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo
64. Macrophages present pinocytosed exogenous antigen via MHC class I whereas antigen ingested by recpetor-mediated endocytosis is presented via MHC class II
65. The binding and lysis of target cells by cytotoxic lymphocytes: Molecular and cellular aspects
66. How do cytotoxic lymphocytes kill their targets?
67. CD28 costimulation increases CD8+ cell suppression of HIV replication
68. High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals
69. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells